Invention Grant
![Diaryl[A, G]quinolizidine compound, preparation method therefor, pharmaceutical composition, and uses thereof](/docs/US/2017-09-05/US09751882B2/abs.jpg.600x600.jpg)
- Patent Title: Diaryl[A, G]quinolizidine compound, preparation method therefor, pharmaceutical composition, and uses thereof
-
Application No.: US14400203Application Date: 2013-05-09
-
Publication No.: US09751882B2Publication Date: 2017-09-05
- Inventor: Hong Liu , Xuechu Zhen , Haifeng Sun , Liyuan Zhu , Wangke Qian , Leiping Yu , Zeng Li , Shengbin Zhou , Wenxian Cai , Hualiang Jiang , Kaixian Chen
- Applicant: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
- Applicant Address: CN Beijing
- Assignee: Kingsound & Partner
- Current Assignee: Kingsound & Partner
- Current Assignee Address: CN Beijing
- Agency: Andrews Kurth Kenyon LLP
- Agent Ping Wang
- Priority: CN201210142903 20120509
- International Application: PCT/CN2013/000549 WO 20130509
- International Announcement: WO2013/166862 WO 20131114
- Main IPC: C07D471/14
- IPC: C07D471/14 ; C07D495/14 ; C07D491/22 ; C07D491/147 ; C07D495/22 ; C07D455/03
![Diaryl[A, G]quinolizidine compound, preparation method therefor, pharmaceutical composition, and uses thereof](/abs-image/US/2017/09/05/US09751882B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to a diarylo[a,g]quinolizidine compound of formula (I), enantiomer, diastereoisomer, racemate, mixture, pharmaceutically acceptable salt, crystalline hydrate or solvate thereof; the preparation method thereof, and uses thereof in preparing an experimental model drugs related to dopamine receptors and 5-HT receptors or a medicament for treating or preventing a disease related to dopamine receptors and 5-HT receptors.
Public/Granted literature
Information query
